While off-label use may be permissible, contraindicated use still has a strong regulatory boundary as reinforced by FDA guidance finalized in 2025.
A batch of antiretroviral drug labels has been updated to include Contraindications with an antidepressant. The Food and Drug Administration (FDA) announced that the following antiretroviral drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback